Single nucleotide polymorphism in genome-wide association of human population: A tool for broad spectrum service

Egyptian Journal of Medical Human Genetics

Volumn 14, Issue 2, 2013, Pages 123-134

  Fareed, Mohd ^a   Afzal, Mohammad ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Disease risk; Drug development; Genetic variation; Human population; SNPs

Indexed keywords

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BIPOLAR DISORDER; CELIAC DISEASE; CORONARY ARTERY DISEASE; CROHN DISEASE; ENTERITIS; GALLSTONE; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC VARIABILITY; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; MULTIPLE SCLEROSIS; MYOCARDIAL BRIDGING; NON INSULIN DEPENDENT DIABETES MELLITUS; RESTLESS LEGS SYNDROME; REVIEW; RHEUMATOID ARTHRITIS; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84893653912     PISSN: 11108630     EISSN: 20902441     Source Type: Journal    
DOI: 10.1016/j.ejmhg.2012.08.001     Document Type: Review

References (122)

1. Chakravarti A. To a future of genetic medicine. Nature 2001, 409(6822):822-823.
2. Kato N., Takeuchi F., Tabara Y., et al. Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nat Genet 2011, 43:531-538.
3. Soranzo N., Spector T.D., Mangino M., et al. A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet 2009, 41:1182-1190.
4. Marchini J., Howie B., Myers S., McVean G., Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 2007, 39:906-913.
5. Frazer K.A., Ballinger D.G., Cox D.R., et al. International HapMap Consortium. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007, 449:851-861.
6. Gabriel S.B., Schaffner S.F., Nguyen H., et al. The structure of haplotype blocks in the human genome. Science 2002, 296:2225-2229.
7. Spencer C.C., Su Z., Donnelly P., Marchini J. Designing genome-wide association studies: sample size, power, imputation, and the choice of genotyping chip. PLoS Genet 2009, 5:e1000477.
8. Sirén J., Marttinen P., Corander J. Reconstructing population histories from single nucleotide polymorphism data. Mol Biol Evol 2011, 28:673-683.
9. Hunter D.J., Kraft P. Drinking from the fire hose-statistical issues in genomewide association studies. N Engl J Med 2007, 357:436-439.
10. Hoover R.N. The evolution of epidemiologic research: from cottage industry to " big" science. Epidemiology 2007, 18:13-17.
11. Easton D.F., Pooley K.A., Dunning A.M., et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007, 447:1087-1093.
12. Thomas G., Jacobs K.B., Yeager M., et al. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 2008, 40:310-315.
13. Pearson T.A., Manolio T.A. How to interpret a genome-wide association study. JAMA 2008, 299:1335-1344.
14. Giacopelli F., Marciano R., Pistorio A., Catarsi P., Canini S., Karsenty G., et al. Polymorphisms in the osteopontin promoter affect its transcriptional activity. Physiol Genomics 2004, 20:87-96.
15. Gudmundsson J., Sulem P., Gudbjartsson D.F., et al. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 2009, 41:460-464.
16. Egli R.J., Southam L., Wilkins J.M., Lorenzen I., Pombo-Suarez M., Gonzalez A., et al. Functional analysis of the osteoarthritis susceptibility-associated GDF5 regulatory polymorphism. Arthritis Rheum 2009, 60:2055-2064.
17. Zhang H., Gelernter J., Gruen J.R., Kranzler H.R., Herman A.I., Simen A.A. Functional impact of a single-nucleotide polymorphism in the OPRD1 promoter region. J Hum Genet 2010, 55:278-284.
18. Salavaggione O.E., Wang L., Wiepert M., Yee V.C., Weinshilboum R.M. Thiopurine S-methyltransferase pharmacogenetics: variant allele functional and comparative genomics. Pharmacogenet Genomics 2005, 15:801-815.
19. Lennard L., Van Loon J.A., Weinshilboum R.M. Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism. Clin Pharmacol Ther 1989, 46:149-154.
20. Huang P., Chen C., Mague S.D., Blendy J.A., Liu-Chen L.Y. A common single nucleotide polymorphism A118G of the μ opioid receptor alters its N-glycosylation and protein stability. Biochem J 2012, 441:379-386.
21. Curran M.E., Splawski I., Timothy K.W., Vincent G.M., Green E.D., Keating M.T. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995, 80:795-803.
22. Gentile S., Martin N., Scappini E., Williams J., Erxleben C., Armstrong D.L. The human ERG1 channel polymorphism, K897T, creates a phosphorylation site that inhibits channel activity. Proc Natl Acad Sci USA 2008, 105:14704-14708.
23. Hardy J., Singleton A. Genomewide association studies and human disease. N Engl J Med 2009, 360:1759-1768.
24. Manolio T.A., Brooks L.D., Collins F.S.A. A HapMap harvest of insights into the genetics of common disease. J Clin Invest 2008, 118:1590-1605.
25. Scott L.J., Mohlke K.L., Bonnycastle L.L., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007, 316:1341-1345.
26. Kan Y.W., Dozy A.M. Polymorphism of DNA sequence adjacent to human beta-globin structural gene: relationship to sickle mutation. Proc Natl Acad Sci USA 1978, 75:5631-5635.
27. Buchanan C.C., Torstenson E.S., Bush W.S., Ritchie M.D. A comparison of cataloged variation between International HapMap Consortium and 1000 Genomes Project data. J Am Med Inform Assoc 2012, 19:289-294.
28. Schadt E.E. Molecular networks as sensors and drivers of common human diseases. Nature 2009, 10461:218-223.
29. Zhao S., Iyengar R. Systems pharmacology: network analysis to identify multiscale mechanisms of drug action. Annu Rev Pharmacol Toxicol 2012, 52:505-521.
30. Sakata T., Anzai N., Kimura T., Miura D., Fukutomi T., et al. Functional analysis of human organic cation transporter OCT3 SLC22A3 polymorphisms. J Pharmacol Sci 2010, 113:263-266.
31. Hartmann T., Terao M., Garattini E., Teutloff C., Alfaro J.F., Jones J.P., et al. The impact of single nucleotide polymorphisms on human aldehyde oxidase. Drug Metab Dispos 2012, 40:856-864.
32. Johnson J.A., Gong L., Whirl-Carrillo M., Gage B.F., Scott S.A., Stein C.M., et al. Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin Pharmacol Ther 2011, 90:625-629.
33. Lucena M.I., Andrade R.J., Martinez C., Ulzurrun E., Garcia-Martin E., Borraz Y., et al. Glutathione S-transferase m1 and t1 null geno-types increase susceptibility to idio-syncratic drug-induced liver injury. Hepatology 2008, 48:588-596.
34. Lucena M.I., García-Martín E., Andrade R.J., et al. Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-induced liver injury. Hepatology 2010, 52:303-312.
35. Andrade R.J., Agundez J.A., Lucena M.I., Martinez C., Cueto R., Garcia-Martin E. Pharmacogenomics in drug induced liver injury. Curr Drug Metab 2009, 10:956-970.
36. Kim H.C., Lee J.Y., Sung H., et al. A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study. Breast Cancer Res 2012, 14:R56.
37. Hunter D.J., Kraft P., Jacobs K.B., et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007, 39:870-874.
38. Stacey S.N., Manolescu A., Sulem P., et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 2007, 39:865-869.
39. Stacey S.N., Gudbjartsson D.F., Sulem P., et al. Common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigmentation traits. Nat Genet 2008, 40:1313-1318.
40. Stacey S.N., Sulem P., Masson G., et al. New common variants affecting susceptibility to basal cell carcinoma. Nat Genet 2009, 41:909-914.
41. Gudmundsson J., Sulem P., Manolescu A., et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 2007, 39:631-637.
42. Yeager M., Orr N., Hayes R.B., Jacobs K.B., et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007, 39:645-649.
43. Gudmundsson J., Sulem P., Steinthorsdottir V., et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 2007, 39:977-983.
44. Eeles R.A., Kote-Jarai Z., Al Olama A.A., et al. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet 2009, 41:1116-1121.
45. Zanke B.W., Greenwood C.M., Rangrej J., et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet 2007, 39:989-994.
46. Broderick P., Carvajal-Carmona L., Pittman A.M., et al. A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat Genet 2007, 39:1315-1317.
47. Hung R.J., McKay J.D., Gaborieau V., et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008, 452:633-637.
48. Landi M.T., Chatterjee N., Yu K., et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet 2009, 85:679-691.
49. Brown K.M., Macgregor S., Montgomery G.W., et al. Common sequence variants on 20q11.22 confer melanoma susceptibility. Nat Genet 2008, 40:838-840.
50. Bishop D.T., Demenais F., Iles M.M., et al. Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet 2009, 41:920-925.
51. Maris J.M., Mosse Y.P., Bradfield J.P., et al. Chromosome 6p22 locus associated with clinically aggressive neuroblastoma. N Engl J Med 2008, 358:2585-2593.
52. Capasso M., Devoto M., Hou C., et al. Common variations in BARD1 influence susceptibility to high-risk neuroblastoma. Nat Genet 2009, 41:718-723.
53. Song H., Ramus S.J., Tyrer J., et al. A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet 2009, 419:996-1000.
54. Mead S., Poulter M., Uphill J., et al. Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study. Lancet Neurol 2009, 8:57-66.
55. Khor C.C., Chau T.N., Pang J., et al. Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1. Nat Genet 2011, 43:1139-1141.
56. Kamatani Y., Wattanapokayakit S., Ochi H., et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 2009, 41:591-595.
57. Rauch A., Kutalik Z., Descombes P., et al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 2010, 138:1338-1345.
58. Fellay J., Shianna K.V., Ge D., et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007, 317:944-947.
59. Fellay J., Ge D., Shianna K.V., Colombo S., et al. Common genetic variation and the control of HIV-1 in humans. PLoS Genet 2009, 5:e1000791.
60. Pelak K., Goldstein D.B., Walley N.M., et al. Host determinants of HIV-1 control in African Americans. J Infect Dis 2010, 201:1141-1149.
61. Pereyra F., Jia X., McLaren P.J., et al. The International HIV Controllers Study. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010, 330:1551-1557.
62. Troyer J.L., Nelson G.W., Lautenberger J.A., et al. Genome-wide association study implicates PARD3B-based AIDS restriction. J Infect Dis 2011, 203:1491-1502.
63. Limou S., Le Clerc S., Coulonges C., et al. Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes ANRS genomewide association study 02. J Infect Dis 2009, 199:419-426.
64. Limou S., Coulonges C., Herbeck J.T., et al. Multiple-cohort genetic association study reveals CXCR6 as a new chemokine receptor involved in long-term nonprogression to AIDS. J Infect Dis 2010, 202:908-915.
65. Zhang F.R., Huang W., Chen S.M., et al. Genomewide association study of leprosy. N Engl J Med 2009, 361:2609-2618.
66. Davila S., Wright V.J., Khor C.C., et al. Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. Nat Genet 2010, 42:772-776.
67. Jallow M., Teo Y.Y., Small K.S., et al. Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat. Genet 2009, 41:657-665.
68. Thye T., Vannberg F.O., Wong S.H., et al. Genome--wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2. Nat Genet 2010, 42:739-741.
69. Stahl E.A., Raychaudhuri S., Remmers E.F., et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010, 42:508-514.
70. Plenge R.M., Seielstad M., Padyukov L., et al. TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study. N Engl J Med 2007, 357:1199-1209.
71. Plenge R.M., Cotsapas C., Davies L., et al. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet 2007, 39:1477-1482.
72. Kozyrev S.V., Abelson A.K., Wojcik J., et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet 2008, 40:211-216.
73. Gudbjartsson D.F., Arnar D.O., Helgadottir A., et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007, 448:353-357.
74. Burton P.R., Clayton D.G., Cardon L.R., et al. Wellcome Trust Case Control Consortium (WTCCC). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661-678.
75. Samani N.J., Erdmann J., Hall A.S., et al. Genomewide association analysis of coronary artery disease. N Engl J Med 2007, 357:443-453.
76. Harrison S.C., Cooper J.A., Li K., et al. Association of a sequence variant in DAB2IP with coronary heart disease. Eur Heart J 2012, 33:881-888.
77. Helgadottir A., Thorleifsson G., Manolescu A., et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007, 316:1491-1493.
78. Smyth D.J., Cooper J.D., Howson J.M., Clarke P., Downes K., Mistry T., et al. FUT2 nonsecretor status links type 1 diabetes susceptibility and resistance to infection. Diabetes 2011, 60:3081-3084.
79. Todd J.A., Walker N.M., Cooper J.D., et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007, 39:857-864.
80. Hakonarson H., Grant S.F., Bradfield J.P., et al. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 2007, 448:591-594.
81. van Vliet-Ostaptchouk J.V., van Haeften T.W., Landman G.W., et al. Common variants in the type 2 diabetes KCNQ1 gene are associated with impairments in insulin secretion during hyperglycaemic glucose clamp. PLoS One 2012, 7:e32148.
82. Sladek R., Rocheleau G., Rung J., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445:881-885.
83. Zeggini E., Weedon M.N., Lindgren C.M., et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007, 316:1336-1341.
84. Saxena R., Voight B.F., Lyssenko V., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007, 316:1331-1336.
85. Van Heel D.A., Franke L., Hunt K.A., et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet 2007, 39:827-829.
86. Libioulle C., Louis E., Hansoul S., Sandor C., et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet 2007, 3:e58.
87. Parkes M., Barrett J.C., Prescott N.J., et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet 2007, 39:830-832.
88. Rioux J.D., Xavier R.J., Taylor K.D., et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007, 39:596-604.
89. Buch S., Schafmayer C., Völzke H., et al. A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat Genet 2007, 39:995-999.
90. Duerr R.H., Taylor K.D., Brant S.R., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006, 314:1461-1463.
91. Kathiresan S., Melander O., Guiducci C., et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 2008, 40:189-197.
92. Willer C.J., Sanna S., Jackson A.U., et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 2008, 40:161-169.
93. Wallace C., Newhouse S.J., Braund P., et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet 2008, 82:139-149.
94. Kooner J.S., Chambers J.C., Aguilar-Salinas C.A., et al. Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides. Nat Genet 2008, 40:149-151.
95. van Es M.A., van Vught P.W., Blauw H.M., et al. Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis. Nat Genet 2008, 40:29-31.
96. Reiman E.M., Webster J.A., Myers A.J., et al. GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron 2007, 54:713-720.
97. Baum A.E., Akula N., Cabanero M., et al. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 2008, 13:197-207.
98. Al Jumah M, Al Balwi M, Hussein M, Kojan S, Al Khathaami A, Al Fawaz M, et al. Association of SNPs rs6498169 and rs10984447 with multiple sclerosis in Saudi patients: a model of the usefulness of familial aggregates in identifying genetic linkage in a multifactorial disease. Mult Scler 2012. doi:10.1177/1352458512440832.
99. Hafler D.A., Compston A., Sawcer S., et al. International Multiple Sclerosis Genetics Consortium. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007, 357:851-862.
100. Stefansson H., Rye D.B., Hicks A., et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med 2007, 357:639-647.
101. Winkelmann J., Schormair B., Lichtner P., et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 2007, 39:1000-1006.
102. Lencz T., Morgan T.V., Athanasiou M., Dain B., Reed C.R., Kane J.M., et al. Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia. Mol Psychiatry 2007, 12:572-580.
103. Schymick J.C., Scholz S.W., Fung H.C., et al. Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol 2007, 6:322-328.
104. Food and Drug Administration, 2012. Table of pharmacogenomic biomarkers in drug labels. Available at: http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm.
105. Ando Y., Saka H., Ando M., Sawa T., Muro K., Ueoka H., et al. Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis. Cancer Res 2000, 60:6921-6926.
106. Mallal S., Phillips E., Carosi G., et al. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 2008, 358:568-579.
107. Halder I., Shriver M.D. Measuring and using admixture to study the genetics of complex diseases. Hum Genomics 2003, 1:52-62.
108. Hu D., Ziv E. Confounding in genetic association studies and its solutions. Methods Mol Biol 2008, 448:31-39.
109. Liu C., Batliwalla F., Li W., et al. Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis. Mol Med 2008, 14:575-581.
110. Barrett J.C., Hansoul S., Nicolae D.L., et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008, 40:955-962.
111. Yang Q., Cui J., Chazaro I., Cupples L.A., Demissie S. Power and type I error rate of false discovery rate approaches in genome-wide association studies. BMC Genet 2005, 6(Suppl 1):S134.
112. Van der Helmvan Mil A.H., Padyukov L., Toes R.E., Klareskog L., Huizinga T.W. Genome-wide single-nucleotide polymorphism studies in rheumatology: hype or hope?. Arthritis Rheum 2008, 58:2591-2597.
113. Johnson J.A., Lima J.J. Drug receptor/effector polymorphisms and pharmacogenetics: current status and challenges. Pharmacogenetics 2003, 13:525-534.
114. Jacobson E.M., Concepcion T., Oashi Y., Tomer A. Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. Endocrinology 2005, 146(6):2684-2691.
115. Wachtel C., Manley J.L. Splicing of mRNA precursors: the role of RNAs and proteins in catalysis. Mol Biosyst 2009, 5:311-316.
116. Pagani F., Stuani C., Tzetis M., Kanavakis E., Efthymiadou A., Doudounakis S., et al. New type of disease causing mutations: the example of the composite exonic regulatory elements of splicing in CFTR exon. Hum Mol Genet 2003, 12(10):1111-1120.
117. Giacopelli F., Marciano R., Pistorio A., Catarsi P., Canini S., Karsenty G., et al. Polymorphisms in the osteopontin promoter affect its transcriptional activity. Physiol Genomics 2004, 20(1):87-96.
118. Wang Z., Moult J. SNPs, protein structure, and disease. Hum Mutat 2001, 4:263-270.
119. *5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet 2009, 41:816-819.
120. Kindmark A., Jawaid A., Harbron C.G., Barratt B.J., Bengtsson O.F., et al. Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis. Pharmacogenomics J 2008, 8:186-195.
121. Lucena M.I., Molokhia M., Shen Y., Urban T.J., Aithal G.P., et al. Susceptibility to amoxicillinclavulanate-induced liver injury is influenced by multipleHLA class I and class II alleles. Gastroenterology 2011, 141:338-347.
122. Singer J.B., Lewitzky S., Leroy E., Yang F., Zhao X., et al. A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury. Nat Genet 2010, 42:711-714.